Gilead to End Coronavirus Drug Trials, Adding to Access Worry: Researchers

Friday, 15 May 2020

Gilead to End Coronavirus Drug Trials, Adding to Access Worry: Researchers

in published on May 15, 2020 leave a reply
Preliminary results from a trial conducted by the US National Institutes of Health showed that Remdesivir cut hospital stays by 31% compared to a placebo.

from Top Business News- News18.com https://ift.tt/3dUnO2v
Previous Post
Next Post
Rohit

post written by:

0 comments: